AKT1 and endometrial cancer: In endometrial cancer cells, the RAS-RAF and PI3K-Akt-mTOR pathways are activated via receptor tyrosine kinases, including involvement of PTEN in the PI3K-Akt-mTOR pathway (Fig. 2).